Integrated, High-Throughput, Multiomics Platform Enables Data-Driven Construction of Cellular Responses and Reveals Global Drug Mechanisms of Action

Jeremy L. Norris(Aristotle University of Thessaloniki), Richard M. Caprioli(Vanderbilt University), Raf Van de Plas(Delft University of Technology), D. Borden Lacy(Vanderbilt University), Ashley Jordan(Vanderbilt University Medical Center), Salisha Hill, Kristie L. Rose(Vanderbilt University Medical Center), John A. McLean(Vanderbilt University), John P. Wikswo(Vanderbilt University), Y.-w. Nei, Jamie Allen(Vanderbilt University), Alexander L. R. Lubbock(Institute of Genetics and Cancer), Carrie Romer, Tina Tsui, Margaret Keller(Vanderbilt University), Stacey A. Rutherford(The University of Texas Health Science Center at Tyler), James C. Pino(Pacific Northwest National Laboratory), Nichole A. Lobdell(Vanderbilt University), Nicole D. Muszynski, Jeffrey M. Spraggins(Vanderbilt University), Stacy D. Sherrod(Vanderbilt University), Lauren D. Palmer(University of Illinois Chicago), Carlos F. Lopez(Vanderbilt University), Eric P. Skaar(Vanderbilt University Medical Center), Danielle Gutierrez, M. Lisa Manier, Nathaniel Braman(Tempus Labs (United States)), James C. Poland(Vanderbilt University), Boone M. Prentice(University of Florida), William J. Burns(Vanderbilt University), Melissa A. Farrow(Vanderbilt University)
Journal of Proteome Research
January 15, 2017
Cited by 44


Related Papers